High C-reactive protein in Crohns disease patients predicts nonresponse to infliximab treatment
Journal of Crohn's and Colitis,  Clinical Article

Magro F et al. – Correlate C–reactive protein (CRP) levels before beginning of IFX, at week 14 and CRP delta within the first year of Infliximab (IFX) treatment. CRP levels at week 14 were associated with SR in patients treated with IFX, independently of baseline CRP serum levels. High inflammatory burden at beginning of IFX treatment was correlated with a worse response.

Methods

  • Retrospective study of CD patients undergoing treatment with IFX.
  • Primary nonresponse (PNR) was defined as no symptomatic improvement and CRP persistently elevated; sustained response (SR) as symptomatic improvement for at least 1year without therapeutic adjustment; response after therapeutic adjustment (RTA) as analytic and clinical response but requiring IFX dose/frequency adjustment or association with another drug.

Results

  • Baseline CRP levels were higher in PNR compared with SR (26.2mg/L vs 9.6mg/L, p=0.015) and RTA (26.2mg/L vs 7.6mg/L, p=0.007).
  • CRP levels greater than 15mg/L at baseline predict PNR with 67% sensitivity and 65% specificity.
  • Lower CRP levels at week 14 were more likely to predict SR relative to RTA (3.1mg/L vs 7.6mg/L p=0.019) and PNR (3.1mg/L vs 9.1mg/L; p=0.013).
  • CRP levels greater than 4.6mg/L at week 14 predict PNR with 67% sensitivity and 62% specificity.
  • A higher CRP delta between beginning of treatment and week 14 is more likely to predict SR relative to RTA (5.2mg/L vs 0.6mg/L p=0.027).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Gastroenterology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Gastroenterology Articles

1 Screening prior to biological therapy in Crohn's disease: Adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study Digestive and Liver Diseases, August 4, 2014    Clinical Article

2 Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: A randomized, double-blind, placebo-controlled study Journal of Crohn's and Colitis, August 27, 2014    Clinical Article

3 Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50years Journal of Crohn's and Colitis, September 8, 2014    Clinical Article

4 Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up Hepatology, August 22, 2014    Clinical Article

5 Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis Clinical Gastroenterology and Hepatology , September 25, 2014    Clinical Article

6 Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: A meta-analysis Clinical Gastroenterology and Hepatology , September 26, 2014    Evidence Based Medicine

7 Exclusive enteral nutritional therapy can relieve inflammatory bowel stricture in Crohn’s disease Journal of Clinical Gastroenterology, September 17, 2014    Clinical Article

8 Fecal lactoferrin in discriminating inflammatory bowel disease from irritable bowel syndrome: A diagnostic meta-analysis Full Text BMC Gastroenterology, July 14, 2014    Free full text    Evidence Based Medicine

9 Calcium intake and colorectal adenoma risk: Dose-response meta-analysis of prospective observational studies International Journal of Cancer, August 29, 2014    Evidence Based Medicine

10 Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: data from ultra 1, 2, and 3 The American Journal of Gastroenterology, September 10, 2014    Clinical Article

11 Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis Clinical Gastroenterology and Hepatology , June 25, 2014    Evidence Based Medicine    Clinical Article

12 Long-term therapeutic effect of maintenance enteral nutrition for Crohn's disease Pediatrics International, September 16, 2014    Clinical Article

13 Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: A meta-analysis The American Journal of Gastroenterology, September 24, 2014    Evidence Based Medicine

14 A prospective, randomized, controlled, exploratory study of comprehensive dietary advice in ulcerative colitis: impact on disease activity and quality of life European Journal of Gastroenterology & Hepatology, July 10, 2014    Clinical Article

15 Placebo response rate in clinical trials of fistulizing Crohn’s disease: Systematic review and meta-analysis Clinical Gastroenterology and Hepatology , September 22, 2014    Evidence Based Medicine    Review Article

16 Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study Alimentary Pharmacology and Therapeutics, September 5, 2014    Clinical Article

17 Long intestinal tube splinting really prevent recurrence of postoperative adhesive small bowel obstruction? A study of 1071 cases The American Journal of Surgery, July 23, 2014    Clinical Article

18 Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease Alimentary Pharmacology and Therapeutics, September 11, 2014    Clinical Article

19 The management of Crohn's disease and ulcerative colitis during pregnancy and lactation Alimentary Pharmacology and Therapeutics, September 12, 2014    Review Article

20 Plasma 25-hydroxyvitamin D and risk of colorectal cancer after adjusting for inflammatory markers Cancer Epidemiology, Biomarkers & Prevention, August 15, 2014    Clinical Article

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close